1. Home
  2. NSSC vs DAWN Comparison

NSSC vs DAWN Comparison

Compare NSSC & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NAPCO Security Technologies Inc.

NSSC

NAPCO Security Technologies Inc.

HOLD

Current Price

$42.63

Market Cap

1.4B

ML Signal

HOLD

Logo Day One Biopharmaceuticals Inc.

DAWN

Day One Biopharmaceuticals Inc.

HOLD

Current Price

$11.42

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NSSC
DAWN
Founded
1969
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.1B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
NSSC
DAWN
Price
$42.63
$11.42
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
9
Target Price
$48.17
$27.56
AVG Volume (30 Days)
478.9K
3.1M
Earning Date
02-02-2026
02-27-2026
Dividend Yield
1.40%
N/A
EPS Growth
0.75
N/A
EPS
1.32
N/A
Revenue
$192,025,000.00
$133,672,000.00
Revenue This Year
$13.32
$18.27
Revenue Next Year
$9.84
$48.39
P/E Ratio
$32.59
N/A
Revenue Growth
2.94
31.11
52 Week Low
$19.00
$5.64
52 Week High
$48.12
$13.20

Technical Indicators

Market Signals
Indicator
NSSC
DAWN
Relative Strength Index (RSI) 58.38 54.87
Support Level $41.71 $10.30
Resistance Level $44.27 $11.84
Average True Range (ATR) 1.68 0.79
MACD 0.54 -0.10
Stochastic Oscillator 73.59 39.44

Price Performance

Historical Comparison
NSSC
DAWN

About NSSC NAPCO Security Technologies Inc.

NAPCO Security Technologies Inc manufactures security products, encompassing access control systems, door-locking products, intrusion and fire alarm systems and video surveillance products. Its products are used for various applications which includes alarm systems like automatic communicators, combination control panels/digital communicators and digital keypad systems, fire alarm control panel and area detectors mainly used for commercial, residential, institutional, industrial and governmental uses. Geographically, the company derives a majority of its revenue from the United States.

About DAWN Day One Biopharmaceuticals Inc.

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.

Share on Social Networks: